Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Long noncoding RNA DHRS4 antisense RNA 1 suppresses osteosarcoma cell proliferation and promotes apoptosis through a
Zhouzhou Tang1,2, Zhihao Li2, Guofeng Wu3
1Department of Spinal Surgery, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue Central Guangzhou, Guangdong510280, Guangzhou, Guangdong510280, China.
Abstract:
Osteosarcoma (OS) is the most common primary malignant bone tumor. Recent evidence suggests that the novel long noncoding RNA DHRS4 antisense RNA 1 (DHRS4-AS1) serves an important role in cancer progression and metastasis. However, its function and molecular mechanism in OS remain largely unknown. In the present study, DHRS4-AS1 expression was detected in OS cells by quantitative PCR. Gain- and loss-of-function experiments were conducted to study the effects of DHRS4-AS1 on the proliferation and apoptosis of OS cells. The potential mechanism of DHRS4-AS1 was examined through bioinformatics analysis and rescue experiments. DHRS4-AS1 was downregulated in OS cell lines. DHRS4-AS1 depletion promoted proliferation and inhibited apoptosis in OS cells, whereas DHRS4-AS1 overexpression had the opposite effects. Further research suggested that DHRS4-AS1 inhibited OS progression by regulating the microRNA-362-5p/aminopeptidase puromycin sensitive axis. The present findings suggested that DHRS4-AS1 may serve as a potential therapeutic target for OS.
Insights
The long noncoding RNA DHRS4 antisense RNA 1 (DHRS4-AS1) is downregulated in osteosarcoma (OS). Restoring DHRS4-AS1 inhibits OS cell proliferation and promotes apoptosis, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma (OS) is the most common primary malignant bone tumor.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- The specific function of DHRS4 antisense RNA 1 (DHRS4-AS1) in OS is largely unknown.
Purpose of the Study:
- To investigate the expression, function, and molecular mechanism of DHRS4-AS1 in osteosarcoma.
- To determine if DHRS4-AS1 can serve as a potential therapeutic target for OS.
Main Methods:
- Quantitative PCR to detect DHRS4-AS1 expression in OS cell lines.
- Gain- and loss-of-function experiments to assess the impact of DHRS4-AS1 on OS cell proliferation and apoptosis.
- Bioinformatics analysis and rescue experiments to elucidate the underlying molecular mechanism.
Main Results:
- DHRS4-AS1 expression was found to be downregulated in OS cell lines.
- DHRS4-AS1 depletion promoted OS cell proliferation and inhibited apoptosis.
- DHRS4-AS1 overexpression exhibited opposite effects, suppressing proliferation and enhancing apoptosis.
- DHRS4-AS1 was shown to inhibit OS progression by regulating the microRNA-362-5p/aminopeptidase puromycin sensitive axis.
Conclusions:
- DHRS4-AS1 plays a crucial role in regulating osteosarcoma cell proliferation and apoptosis.
- DHRS4-AS1 functions as a tumor suppressor in osteosarcoma.
- DHRS4-AS1 represents a potential therapeutic target for osteosarcoma treatment.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
RNA Performs Diverse...

